Chordate Medical Holding AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 0.538487 million. Revenue was SEK 0.685495 million compared to SEK 0.011912 million a year ago. Net loss was SEK 4.94 million compared to SEK 6.14 million a year ago. Basic loss per share from continuing operations was SEK 0.02 compared to SEK 0.04 a year ago.
For the nine months, sales was SEK 1.1 million compared to SEK 0.08817 million a year ago. Revenue was SEK 1.25 million compared to SEK 0.123296 million a year ago. Net loss was SEK 19.34 million compared to SEK 19.48 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.12 a year ago.